Literature DB >> 3382267

Peptic ulcer in rheumatoid arthritis.

D Farah1, R D Sturrock, R I Russell.   

Abstract

In a study of patients attending a rheumatology clinic 230 unselected patients, 185 with rheumatoid arthritis (RA) and 45 with other rheumatic disorders (non-RA), were examined by endoscopy and a detailed history of symptoms referable to the gastrointestinal tract was taken. A peptic ulcer was found in 67 (36%) of the patients and in 13 (29%) of the non-RA group. Gastric ulceration was more common in the group with RA (32 patients (17%) compared with three patients (7%) in the non-RA group); 17/32 (53%) patients with RA and gastric ulcer were asymptomatic. In the group with RA, of those with gastric ulcer 20/32 (63%) were smokers, compared with only 40/118 (34%) of the non-ulcer group. There was no difference in the duration of rheumatic disease or non-steroidal anti-inflammatory drug (NSAID) treatment between the ulcer and non-ulcer groups. Treatment with H2 receptor antagonist and maintenance of NSAID treatment resulted in healing in 26 out of 29 (90%) patients with gastric ulcer and 23 out of 27 (85%) patients with duodenal ulcer.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3382267      PMCID: PMC1003549          DOI: 10.1136/ard.47.6.478

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

1.  Serum immunoreactive gastrin: specificity for rheumatoid arthritis, bimodality of distribution, and failure of effect of anti-inflammatory drugs.

Authors:  P J Rooney; D M Grennan; R D Sturrock; P M Brooks; W C Dick
Journal:  Ann Rheum Dis       Date:  1976-02       Impact factor: 19.103

2.  Gastric ulceration occurring during indomethacin therapy.

Authors:  R T Taylor; E C Huskisson; G H Whitehouse; F D Hart; D H Trapnell
Journal:  Br Med J       Date:  1968-12-21

3.  Ulcers and anti-inflammatory agents.

Authors:  W S Mitchell; R D Sturrock
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-06

4.  Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer.

Authors:  K Somerville; G Faulkner; M Langman
Journal:  Lancet       Date:  1986-03-01       Impact factor: 79.321

5.  Non-steroidal anti-inflammatory drugs and peptic ulcer perforation.

Authors:  D S Collier; J A Pain
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

6.  Cimetidine in patients with gastric ulcer: a multicentre controlled trial.

Authors:  F Frost; I Rahbek; S J Rune; K B Jensen; E Gudmand-Hoyer; E Krag; J Rask-Madsen; H R Wulff; J Garbol; K G Jensen; M Hojlund; V R Nissen
Journal:  Br Med J       Date:  1977-09-24

7.  Gastroscopic evaluation of anti-inflammatory agents.

Authors:  I Caruso; G Bianchi Porro
Journal:  Br Med J       Date:  1980-01-12

8.  Cimetidine for peptic ulcer in patients with arthritis.

Authors:  J R Croker; P B Cotton; A C Boyle; P Kinsella
Journal:  Ann Rheum Dis       Date:  1980-06       Impact factor: 19.103

9.  Smoking and peptic ulcer in rheumatoid arthritis.

Authors:  J M Willoughby; W K Essigman; J C Weber; R F Pinerua
Journal:  Clin Exp Rheumatol       Date:  1986 Jan-Mar       Impact factor: 4.473

10.  Healing of aspirin-associated peptic ulcer disease despite continued salicylate ingestion.

Authors:  J C O'Laughlin; G R Silvoso; K J Ivey
Journal:  Arch Intern Med       Date:  1981-05
View more
  20 in total

Review 1.  Non-steroidal anti-inflammatory drugs and peptic ulcers.

Authors:  C J Hawkey
Journal:  BMJ       Date:  1990-02-03

2.  Decreased salivary epidermal growth factor in rheumatoid disease: a possible mechanism for increased susceptibility to gastric ulceration.

Authors:  S M Kelly; J Crampton; J O Hunter
Journal:  BMJ       Date:  1990-09-01

Review 3.  Drug toxicity.

Authors:  H A Bird
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

Review 4.  Non-steroidal anti-inflammatory drugs in patients with peptic ulcer disease: to be considered in certain circumstances.

Authors:  M Doherty
Journal:  BMJ       Date:  1989-01-21

5.  The cost effectiveness of diclofenac plus misoprostol compared with diclofenac monotherapy in patients with rheumatoid arthritis.

Authors:  M J Al; B C Michel; F F Rutten
Journal:  Pharmacoeconomics       Date:  1996-08       Impact factor: 4.981

6.  Peptic ulcer in rheumatoid arthritis.

Authors:  S H Roth
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

7.  Anaemia in rheumatoid arthritis.

Authors:  A Doube
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

8.  Duodenal histology, ulceration, and Helicobacter pylori in the presence or absence of non-steroidal anti-inflammatory drugs.

Authors:  A S Taha; S Dahill; I Nakshabendi; F D Lee; R D Sturrock; R I Russell
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

9.  Increased gastric juice epidermal growth factor after non-steroidal anti-inflammatory drug ingestion.

Authors:  S M Kelly; J R Jenner; R J Dickinson; J O Hunter
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

10.  Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis.

Authors:  A B Hawthorne; Y R Mahida; A T Cole; C J Hawkey
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.